Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays

Xiaofang Bian, Garrick Wallstrom, Amy Davis, Jie Wang, Jin Park, Andrea Throop, Jason Steel, Xiaobo Yu, Clive Wasserfall, Desmond Schatz, Mark Atkinson, Ji Qiu, Joshua LaBaer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The rapid rise in the incidence of type 1 diabetes (T1D) suggests the involvement of environmental factors including viral infections. We evaluated the association between viral infections and T1D by profiling antiviral antibodies using a high-throughput immunoproteomics approach in patients with new-onset T1D.We constructed a viral protein array comprising the complete proteomes of seven viruses associated with T1D and open reading frames from other common viruses. Antibody responses to 646 viral antigens were assessed in 42 patients with T1D and 42 age- and sex-matched healthy control subjects (mean age 12.7 years, 50% males). Prevalence of antiviral antibodies agreed with known infection rates for the corresponding virus based on epidemiological studies. Antibody responses to Epstein-Barr virus (EBV) were significantly higher in case than control subjects (odds ratio 6.6; 95% CI 2.0-25.7), whereas the other viruses showed no differences. The EBV and T1D association was significant in both sex and age subgroups (≤12 and >12 years), and there was a trend toward early EBV infections among the case subjects. These results suggest a potential role for EBV in T1D development. We believe our innovative immunoproteomics platform is useful for understanding the role of viral infections in T1D and other disorders where associations between viral infection and disease are unclear.

Original languageEnglish (US)
Pages (from-to)285-296
Number of pages12
JournalDiabetes
Volume65
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Protein Array Analysis
Type 1 Diabetes Mellitus
Antiviral Agents
Virus Diseases
Antibodies
Human Herpesvirus 4
Viruses
Antibody Formation
Epstein-Barr Virus Infections
Viral Antigens
Viral Proteins
Proteome
Open Reading Frames
Epidemiologic Studies
Healthy Volunteers
Odds Ratio
Incidence
Infection

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays. / Bian, Xiaofang; Wallstrom, Garrick; Davis, Amy; Wang, Jie; Park, Jin; Throop, Andrea; Steel, Jason; Yu, Xiaobo; Wasserfall, Clive; Schatz, Desmond; Atkinson, Mark; Qiu, Ji; LaBaer, Joshua.

In: Diabetes, Vol. 65, No. 1, 01.01.2016, p. 285-296.

Research output: Contribution to journalArticle

Bian, X, Wallstrom, G, Davis, A, Wang, J, Park, J, Throop, A, Steel, J, Yu, X, Wasserfall, C, Schatz, D, Atkinson, M, Qiu, J & LaBaer, J 2016, 'Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays', Diabetes, vol. 65, no. 1, pp. 285-296. https://doi.org/10.2337/db15-0179
Bian, Xiaofang ; Wallstrom, Garrick ; Davis, Amy ; Wang, Jie ; Park, Jin ; Throop, Andrea ; Steel, Jason ; Yu, Xiaobo ; Wasserfall, Clive ; Schatz, Desmond ; Atkinson, Mark ; Qiu, Ji ; LaBaer, Joshua. / Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays. In: Diabetes. 2016 ; Vol. 65, No. 1. pp. 285-296.
@article{7bc689c12d5a447db6e8483b06bf917d,
title = "Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays",
abstract = "The rapid rise in the incidence of type 1 diabetes (T1D) suggests the involvement of environmental factors including viral infections. We evaluated the association between viral infections and T1D by profiling antiviral antibodies using a high-throughput immunoproteomics approach in patients with new-onset T1D.We constructed a viral protein array comprising the complete proteomes of seven viruses associated with T1D and open reading frames from other common viruses. Antibody responses to 646 viral antigens were assessed in 42 patients with T1D and 42 age- and sex-matched healthy control subjects (mean age 12.7 years, 50{\%} males). Prevalence of antiviral antibodies agreed with known infection rates for the corresponding virus based on epidemiological studies. Antibody responses to Epstein-Barr virus (EBV) were significantly higher in case than control subjects (odds ratio 6.6; 95{\%} CI 2.0-25.7), whereas the other viruses showed no differences. The EBV and T1D association was significant in both sex and age subgroups (≤12 and >12 years), and there was a trend toward early EBV infections among the case subjects. These results suggest a potential role for EBV in T1D development. We believe our innovative immunoproteomics platform is useful for understanding the role of viral infections in T1D and other disorders where associations between viral infection and disease are unclear.",
author = "Xiaofang Bian and Garrick Wallstrom and Amy Davis and Jie Wang and Jin Park and Andrea Throop and Jason Steel and Xiaobo Yu and Clive Wasserfall and Desmond Schatz and Mark Atkinson and Ji Qiu and Joshua LaBaer",
year = "2016",
month = "1",
day = "1",
doi = "10.2337/db15-0179",
language = "English (US)",
volume = "65",
pages = "285--296",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays

AU - Bian, Xiaofang

AU - Wallstrom, Garrick

AU - Davis, Amy

AU - Wang, Jie

AU - Park, Jin

AU - Throop, Andrea

AU - Steel, Jason

AU - Yu, Xiaobo

AU - Wasserfall, Clive

AU - Schatz, Desmond

AU - Atkinson, Mark

AU - Qiu, Ji

AU - LaBaer, Joshua

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The rapid rise in the incidence of type 1 diabetes (T1D) suggests the involvement of environmental factors including viral infections. We evaluated the association between viral infections and T1D by profiling antiviral antibodies using a high-throughput immunoproteomics approach in patients with new-onset T1D.We constructed a viral protein array comprising the complete proteomes of seven viruses associated with T1D and open reading frames from other common viruses. Antibody responses to 646 viral antigens were assessed in 42 patients with T1D and 42 age- and sex-matched healthy control subjects (mean age 12.7 years, 50% males). Prevalence of antiviral antibodies agreed with known infection rates for the corresponding virus based on epidemiological studies. Antibody responses to Epstein-Barr virus (EBV) were significantly higher in case than control subjects (odds ratio 6.6; 95% CI 2.0-25.7), whereas the other viruses showed no differences. The EBV and T1D association was significant in both sex and age subgroups (≤12 and >12 years), and there was a trend toward early EBV infections among the case subjects. These results suggest a potential role for EBV in T1D development. We believe our innovative immunoproteomics platform is useful for understanding the role of viral infections in T1D and other disorders where associations between viral infection and disease are unclear.

AB - The rapid rise in the incidence of type 1 diabetes (T1D) suggests the involvement of environmental factors including viral infections. We evaluated the association between viral infections and T1D by profiling antiviral antibodies using a high-throughput immunoproteomics approach in patients with new-onset T1D.We constructed a viral protein array comprising the complete proteomes of seven viruses associated with T1D and open reading frames from other common viruses. Antibody responses to 646 viral antigens were assessed in 42 patients with T1D and 42 age- and sex-matched healthy control subjects (mean age 12.7 years, 50% males). Prevalence of antiviral antibodies agreed with known infection rates for the corresponding virus based on epidemiological studies. Antibody responses to Epstein-Barr virus (EBV) were significantly higher in case than control subjects (odds ratio 6.6; 95% CI 2.0-25.7), whereas the other viruses showed no differences. The EBV and T1D association was significant in both sex and age subgroups (≤12 and >12 years), and there was a trend toward early EBV infections among the case subjects. These results suggest a potential role for EBV in T1D development. We believe our innovative immunoproteomics platform is useful for understanding the role of viral infections in T1D and other disorders where associations between viral infection and disease are unclear.

UR - http://www.scopus.com/inward/record.url?scp=84962182170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962182170&partnerID=8YFLogxK

U2 - 10.2337/db15-0179

DO - 10.2337/db15-0179

M3 - Article

VL - 65

SP - 285

EP - 296

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 1

ER -